
Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials
2026-05-21 08:03:47Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 May 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain subdued. The stock’s recent price surge of 12.42% and improved technical signals contrast with flat quarterly financials and weak long-term fundamentals, presenting a complex picture for investors.
Read MoreBoard Meeting Intimation for Meeting Of Directors To Be Held On 13Th August 2026
05-Aug-2026 | Source : BSEChoksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter ended on 30th June 2026;
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Aug-2026 | Source : BSENewspaper publication of information regarding change of RTA
Announcement under Regulation 30 (LODR)-Change in RTA
03-Aug-2026 | Source : BSEIntimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
Corporate Actions
13 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available